• Comparative In Vitro Activity of Sisomicin and Tobramycin

  2026-06-12

  This article examines the pivotal study by Stewart and Bodey, which assessed the in vitro efficacy of sisomicin relative to established aminoglycoside antibiotics, including tobramycin, against a broad spectrum of clinical Gram-negative and Gram-positive isolates. The findings inform antibiotic selection and resistance research protocols in microbiology.

• BMS 309403: FABP4 Inhibitor for Atherosclerosis Research

  2026-06-12

  BMS 309403, a potent and selective FABP4 inhibitor, enables precise interrogation of lipid metabolism and inflammatory processes in macrophages and atherosclerosis models. Using validated protocols and troubleshooting tips, researchers can optimize workflows to dissect the CaN/FoxO1/FABP4 pathway and its therapeutic implications in cardiovascular and metabolic disease.

• 2-APB: Strategic Control of Calcium Signaling for Translatio

  2026-06-11

  Explore how 2-APB (2-aminoethoxydiphenyl borate) enables translational researchers to dissect and modulate intracellular calcium signaling with precision, bridging mechanistic insight and actionable strategy for models of cell injury, autophagy, and cardiovascular disease.

• Thioredoxin System Modulates Chk1 Inhibitor Sensitivity in N

  2026-06-11

  This study reveals that the thioredoxin (Trx) system, via redox regulation of ribonucleotide reductase (RNR), critically determines the sensitivity of non-small cell lung cancer (NSCLC) cells to Chk1 inhibitors. These findings provide mechanistic insight into the limited clinical efficacy of Chk1 inhibitors and suggest that targeting the Trx system may enhance therapeutic outcomes.

• TAI-1: First-in-Class Hec1 Inhibitor for Cancer Research

  2026-06-10

  TAI-1 is a potent, first-in-class Hec1 inhibitor that disrupts mitotic regulation and induces apoptotic cell death in cancer cells. The compound demonstrates nanomolar potency, broad anti-tumor activity, and high selectivity, making it a leading tool for cancer cell proliferation inhibition studies.

• Lipo3K Transfection Reagent: Mechanistic Insights & Advanced

  2026-06-10

  Discover the scientific basis and unique advantages of Lipo3K Transfection Reagent as a lipid transfection reagent for challenging cell types. This article offers a mechanistic deep dive and practical assay guidance, setting it apart from typical transfection guides.

• EZ Cap Cy5 Firefly Luciferase mRNA: Next-Gen Dual-Reporter S

  2026-06-09

  Explore how EZ Cap Cy5 Firefly Luciferase mRNA (5-moUTP) revolutionizes mRNA delivery and real-time tracking with advanced dual-modality imaging. Discover unique mechanistic insights and practical protocol guidance not found in previous reviews.

• EdU Imaging Kits (Cy3): Transforming S-Phase Detection in On

  2026-06-09

  Explore how EdU Imaging Kits (Cy3) are redefining cell proliferation analysis for translational cancer researchers. This article integrates mechanistic insight into S-phase DNA synthesis measurement, interprets new findings on pituitary tumor biology, and delivers strategic guidance on deploying next-generation click chemistry assays—advancing both experimental rigor and clinical impact beyond conventional methods.

• Leucovorin Calcium in Assembloid Models: Applied Protocols &

  2026-06-08

  Leucovorin Calcium empowers translational cancer research by reliably protecting cells from methotrexate-induced growth suppression and enabling robust, physiologically relevant assembloid models. This guide delivers actionable protocols, troubleshooting strategies, and practical insights for maximizing reproducibility and precision in folate metabolism studies.

• Forsythoside E Drives PKM2 Tetramerization for Sepsis Liver

  2026-06-08

  The reference study identifies Forsythoside E as a specific allosteric activator of PKM2 tetramerization, reprogramming macrophage metabolism toward an anti-inflammatory state and alleviating sepsis-induced liver injury in vivo. These findings introduce a robust mechanistic rationale for targeting metabolic-epigenetic axes in septic liver injury models.

• Danazol in Translational Endocrinology: Mechanisms and Model

  2026-06-07

  Explore Danazol’s role in translational endocrinology, including its molecular mechanisms, unique utility in precocious puberty models, and implications for prostate cancer research. This article provides an advanced, evidence-based perspective on Danazol beyond standard protocol guides.

• Imipramine in Cancer Research: Lipid Metabolism and Autophag

  2026-06-06

  Explore how Imipramine, a tricyclic antidepressant, advances cancer research through its effects on lipid metabolism and autophagy. This article offers unique, protocol-focused insights for glioma and leukemia studies, grounded in the latest lipidomics findings.

• Erastin in Redox Homeostasis: Beyond Cancer—Aging, Ferroptos

  2026-06-05

  Explore Erastin as a ferroptosis inducer not only in cancer biology research but also in the emerging context of aging and redox homeostasis. This in-depth analysis unveils new mechanistic insights and practical assay guidance, referencing pivotal discoveries in lens epithelial cell vulnerability.

• Applied Cell Proliferation Analysis with EdU Imaging Kits (C

  2026-06-05

  EdU Imaging Kits (Cy3) transform S-phase DNA synthesis measurement with click chemistry, offering denaturation-free, high-sensitivity detection for cell proliferation. This guide delivers practical protocols, troubleshooting insights, and real-world use cases, bridging reference research and workflow optimization for demanding cell biology applications.

• Kanamycin Sulfate: Applied Protocols in Microbiology Researc

  2026-06-04

  Kanamycin Sulfate is an industry-standard water-soluble antibiotic, pivotal for precise selection in antibiotic resistance and microbiome modulation studies. This article delivers actionable workflows, troubleshooting strategies, and data-backed insights to optimize its use in contemporary microbiology and anti-infection research.

14906 records 1/994 page Next 12345 下5页 Last page